T/GDACM 0120-2023 Active Group standards

T/GDACM 0120-2023 Postoperative integrated traditional Chinese and Western medicine accelerated rehabilitation treatment guideline for differentiated thyroid cancer

T/GDACM 0120-2023 Postoperative integrated traditional Chinese and Western medicine accelerated rehabilitation treatment guideline for differentiated thyroid cancer

Publish Date: 2023-09-15 Implement Date: 2023-09-15 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Download

Basic Information

Standard Code: T/GDACM 0120-2023
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: Integrated medical science and healthcare devices
Publish Date: 2023-09-15
Implement Date: 2023-09-15
Pages: 10 pages

Scope

Main technical content: The incidence of differentiated thyroid cancer is increasing, and the main treatment method is surgery. In promoting the rapid postoperative recovery of patients with differentiated thyroid cancer, traditional Chinese medicine intervention has unique therapeutic effects, including oral administration of traditional Chinese medicine, acupuncture, and external treatment methods. However, there are currently no standardized guidelines for combined Chinese and Western medicine treatment of rapid postoperative recovery of differentiated thyroid cancer at home and abroad, which has affected the promotion of the therapeutic effects of traditional Chinese medicine. Formulating scientific guidelines for rapid postoperative recovery of thyroid cancer through combined Chinese and Western medicine is of great significance for improving clinical efficacy, conducting scientific research, developing new drugs, and promoting traditional Chinese medicine to the world.

Development Information

Pages: 10 pages

Related Standards

Contact Us